Elite Pharmaceuticals Inc. (OTCMKTS:ELTP – Get Free Report) crossed above its 50-day moving average during trading on Thursday . The stock has a 50-day moving average of $0.36 and traded as high as $0.3999. Elite Pharmaceuticals shares last traded at $0.3850, with a volume of 387,855 shares trading hands.
Elite Pharmaceuticals Stock Up 4.1%
The company has a current ratio of 7.34, a quick ratio of 5.44 and a debt-to-equity ratio of 0.05. The firm has a market capitalization of $414.70 million, a PE ratio of 12.84 and a beta of 0.38. The firm has a 50-day moving average of $0.36 and a two-hundred day moving average of $0.41.
Elite Pharmaceuticals Company Profile
Elite Pharmaceuticals, Inc is a U.S.-based specialty pharmaceutical company that acquires, develops and markets both branded and generic pharmaceutical products. Headquartered in Houston, Texas, the company focuses on complex dosage forms—including injectables, sterile formulations and oncology therapies—and seeks to address unmet medical needs through advanced drug delivery technologies. Its product portfolio spans therapeutic areas such as pain management, oncology and cardiovascular care.
Since its founding in 2007, Elite Pharmaceuticals has pursued strategic partnerships and licensing agreements to expand its pipeline and manufacturing capabilities.
Read More
- Five stocks we like better than Elite Pharmaceuticals
- MDA Space Targets US Defense Market With $620M Acquisition
- Carnival’s Second Quarter: Is the Stock Still Complicated?
- Domino’s Stock Slides to 52-Week Low as Investors Digest CEO Change
- Microsoft Solves AI’s Biggest Bottleneck With Chevron Deal
Receive News & Ratings for Elite Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Elite Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
